🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This single-arm, multi-center study is to evaluate Sugemalimab plus platinu...
Status
Recruiting
Location
cancer hospital， Chinese Academy of medical sciences and Peking union medical college
Start Date
2023-10-10
Trial ID
NCT07247227
Treatments Being Tested
The goal of this phase II, open-label, single-arm study is to evaluate the ...
Status
Recruiting
Location
Hunan Cancer Hospital
Start Date
2023-06-14
Trial ID
NCT05940532
Treatments Being Tested
Patients with stage III non-small-cell lung cancer initially evaluated as u...
Status
Unknown
Location
Multiple Locations
Start Date
2023-09-15
Trial ID
NCT06031597
Treatments Being Tested
This study aims to explore the efficacy and safety of immunotherapy (PD-L1 ...
Status
Recruiting
Location
Peking University Cancer Hospital & Institute
Start Date
2025-02-25
Trial ID
NCT06869239
The purpose of this study was to evaluate the safety and efficacy of low-do...
Status
Recruiting
Location
West China Hospital of Sichuan University
Start Date
2024-04-18
Trial ID
NCT06217757
Treatments Being Tested
To observe the effect of preoperative anti-PD-1 monotherapy combined with c...
Status
Completed
Location
Tianjin Medical University Cancer Institute and Hospital
Start Date
2022-03-22
Trial ID
NCT05273827
Treatments Being Tested
The goal of this clinical trial is to evaluate whether individualized seque...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2025-11
Trial ID
NCT07190027
Treatments Being Tested
This is the first prospective clinical study to evaluate the efficacy and s...
Status
Not Yet Recruiting
Location
Zhejiang Cancer Hospital
Start Date
2025-06-16
Trial ID
NCT07035860
Treatments Being Tested
This multicenter, prospective Phase II study investigates a response-adapte...
Status
Active Not Recruiting
Location
National Cancer Center / Cancer Hospital, Chinese Academy of Medical Sciences
Start Date
2026-07-01
Trial ID
NCT07711470
Treatments Being Tested